Cargando…
TRIM3 attenuates apoptosis in Parkinson's disease via activating PI3K/AKT signal pathway
This article aims to study tripartite motif-containing protein 3 (TRIM3) effects on Parkinson's disease (PD). TRIM3 expression in venous blood of PD patients was detected by qRT-PCR. PD mouse model and PD SH-SY5Y cell model were constructed. PD cells were treated by LY294002 (a PI3K inhibitor)....
Autores principales: | Dong, Wenwen, Luo, Bei, Qiu, Chang, Jiang, Xu, Shen, Bo, Zhang, Li, Liu, Weiguo, Zhang, Wenbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835008/ https://www.ncbi.nlm.nih.gov/pubmed/33253119 http://dx.doi.org/10.18632/aging.202181 |
Ejemplares similares
-
Trim32 reduces PI3K–Akt–FoxO signaling in muscle atrophy by promoting plakoglobin–PI3K dissociation
por: Cohen, Shenhav, et al.
Publicado: (2014) -
TRIM21 and PHLDA3 negatively regulate the crosstalk between the PI3K/AKT pathway and PPP metabolism
por: Cheng, Jie, et al.
Publicado: (2020) -
TRIM31 enhances chemoresistance in glioblastoma through activation of the PI3K/Akt signaling pathway
por: Fan, Ming-De, et al.
Publicado: (2020) -
TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K/AKT pathway
por: Sun, Ye, et al.
Publicado: (2017) -
TRIM14 regulates melanoma malignancy via PTEN/PI3K/AKT and STAT3 pathways
por: Chen, Jiangyan, et al.
Publicado: (2021)